Wockhdart has moved higher by over 9% to Rs 416 after the pharmaceutical firm said that its Swiss arm will list on the Berne Stock Exchange in Switzerland today, 19 December 2013.
The stock opened at Rs 385 and touched a high of Rs 421 on the BSE. A combined 6.29 million shares have changed hands on the counter till late noon deals on the BSE and NSE.
Wockhardt Bio AG, Switzerland has allocated 2.35 million ordinary shares of Swiss Franc (CHF) 1 each representing 5% of the post diluted capital for subscription at a price of CHF 5.05 per ordinary share for its initial public offering, Wockhdart said in a regulatory filing.
The ordinary shares of Wockhardt Bio AG are scheduled to be listed on December 19, 2013 on the Berne Stock Exchange, Switzerland, it added.
Wockhardt Bio AG is the holding company for the pharmaceutical and biotech firm's international operations.
Meanwhile, the stock has recovered 24% in past three trading sessions compared to 0.30% rise in benchmark S&P BSE Sensex. The stock hits 52-week low of Rs 337 on December 16.
The stock opened at Rs 385 and touched a high of Rs 421 on the BSE. A combined 6.29 million shares have changed hands on the counter till late noon deals on the BSE and NSE.
Wockhardt Bio AG, Switzerland has allocated 2.35 million ordinary shares of Swiss Franc (CHF) 1 each representing 5% of the post diluted capital for subscription at a price of CHF 5.05 per ordinary share for its initial public offering, Wockhdart said in a regulatory filing.
The ordinary shares of Wockhardt Bio AG are scheduled to be listed on December 19, 2013 on the Berne Stock Exchange, Switzerland, it added.
Wockhardt Bio AG is the holding company for the pharmaceutical and biotech firm's international operations.
Meanwhile, the stock has recovered 24% in past three trading sessions compared to 0.30% rise in benchmark S&P BSE Sensex. The stock hits 52-week low of Rs 337 on December 16.